Gregor Diagnostics is a molecular diagnostics company developing a screening test technology for prostate cancer.
Gregor Diagnostics has raised $242K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2025.
Gregor Diagnostics's investors include First Round Capital, Health Wildcatters, gbeta, Green Park & Golf Ventures.
Gregor Diagnostics is headquartered in Madison, United States.
Gregor Diagnostics is a molecular diagnostics company developing a screening test technology for prostate cancer.
Gregor Diagnostics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Gregor Diagnostics — Funding & Investors." VCBacked, November 4, 2025, https://www.vcbacked.co/company/gregor-diagnostics. Accessed July 19, 2026.
VCBacked. (2025). Gregor Diagnostics — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/gregor-diagnostics
{{cite web |title=Gregor Diagnostics — Funding & Investors |url=https://www.vcbacked.co/company/gregor-diagnostics |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated